WEBArgatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) (1.1)
Hikma launches argatroban injection
WEBHikma’s argatroban is indicated for the prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT) and as an anticoagulant in adult patients with or at risk of HIT undergoing percutaneous coronary intervention (PCI).
Argatroban - Hikma Pharmaceuticals USA Inc. - rxdruglabels.com
WEBApr 11, 2024 · 1 INDICATIONS AND USAGE. 1.1 Heparin-Induced Thrombocytopenia. Argatroban Injection is indicated for prophylaxis or treatment of thrombosis in adult patients with heparin-induced thrombocytopenia (HIT). 1.2 Percutaneous Coronary Intervention.
Argatroban (Hikma Pharmaceuticals USA Inc.): FDA Package Insert
WEBOct 20, 2020 · Hikma Pharmaceuticals USA Inc.: Argatroban is a direct thrombin inhibitor indicated: For prophylaxis or treatment of thrombosis in adult patients with...
Drug Approval Package: Argatroban NDA #203049 - Food and …
WEBArgatroban Injection, 100mg/mL. Company: Hikma Pharmaceuticals Co. Ltd. Application No.: 203049. Approval Date: 01/05/2012. Persons with disabilities having problems accessing the PDF files...
Hikma Pharmaceuticals plc Launches Argatroban Injection
WEBDec 13, 2012 · Hikma Pharmaceuticals plc announced the US launch of argatroban injection, following the approval of its New Drug Application (NDA) by the US Food and Drug Administration (FDA) earlier this year.
Hikma Pharmaceuticals USA 00143955901 - McKesson Medical …
WEBProduct Specifications. More Information. SDS. Professionals Also Viewed. View Full Comparison. Argatroban 1 mg / mL Injection Single-Dose Vial 50 mL Hikma Pharmaceuticals USA 00143955901.
Argatroban - Hikma - AdisInsight - Springer
WEBAn injectable formulation of argatroban has been developed by Hikma Pharmaceuticals for the prophylaxis or treatment of thrombosis in adult patients with.
WEBPlease refer to your Supplemental New Drug Application (sNDA) dated March 21, 2016, received March 21, 2016, and your amendment, submitted pursuant to section 505(b)(2) of the Federal Food, Drug,...
CAPLIN STERILES GETS USFDA APPROVAL FOR ARGATROBAN INJECTION
WEBJan 22, 2021 · Argatroban is used as an anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia. According to IQVIA™ {IMS Health),Argatroban Injection had US sales data of approximately $18 million for the 12-month period ending Sep 2020.